ZA917531B - Isoprenoid phospholipase a2 inhibitors and preparations comprising same - Google Patents

Isoprenoid phospholipase a2 inhibitors and preparations comprising same

Info

Publication number
ZA917531B
ZA917531B ZA917531A ZA917531A ZA917531B ZA 917531 B ZA917531 B ZA 917531B ZA 917531 A ZA917531 A ZA 917531A ZA 917531 A ZA917531 A ZA 917531A ZA 917531 B ZA917531 B ZA 917531B
Authority
ZA
South Africa
Prior art keywords
phospholipase
isoprenoid
preparations
inhibitors
same
Prior art date
Application number
ZA917531A
Other languages
English (en)
Inventor
F Ivy Carroll
Ivy Carroll F
Anita Lewin
Lewin Anita
Kenneth Tramposch
Tramposch Kenneth
Stephen A Steiner
A Steiner Stephen
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of ZA917531B publication Critical patent/ZA917531B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/64—Monocyclic acids with unsaturation outside the aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/20—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by carboxyl groups or halides, anhydrides, or (thio)esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09—Geometrical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA917531A 1990-09-21 1991-09-20 Isoprenoid phospholipase a2 inhibitors and preparations comprising same ZA917531B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/586,159 US5141959A (en) 1990-09-21 1990-09-21 Isoprenoid phospholipase a2 inhibitors and preparations comprising same

Publications (1)

Publication Number Publication Date
ZA917531B true ZA917531B (en) 1992-07-29

Family

ID=24344545

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA917531A ZA917531B (en) 1990-09-21 1991-09-20 Isoprenoid phospholipase a2 inhibitors and preparations comprising same

Country Status (18)

Country Link
US (1) US5141959A (es)
EP (1) EP0476682B1 (es)
JP (1) JP2943089B2 (es)
AT (1) ATE117979T1 (es)
AU (1) AU637756B2 (es)
CA (1) CA2051766A1 (es)
DE (1) DE69107153T2 (es)
DK (1) DK0476682T3 (es)
ES (1) ES2067822T3 (es)
FI (1) FI104168B (es)
GR (1) GR3014944T3 (es)
IE (1) IE66745B1 (es)
IL (1) IL99536A (es)
MX (1) MX9101163A (es)
NZ (1) NZ239844A (es)
OA (1) OA09514A (es)
PT (1) PT99014B (es)
ZA (1) ZA917531B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7189737B2 (en) * 1991-08-09 2007-03-13 Research Triangle Institute Cocaine receptor binding ligands
US5688781A (en) 1994-08-19 1997-11-18 Bristol-Myers Squibb Company Method for treating vascular leak syndrome
FR2735371B1 (fr) * 1995-06-19 1997-07-18 Cird Galderma Procede pour identifier des composes antagonistes des recepteurs rars
US6900228B1 (en) 1998-03-10 2005-05-31 Research Triangle Institute Opiate compounds, methods of making and methods of use
US6267945B1 (en) * 1998-12-18 2001-07-31 Neuromed Technologies, Inc. Farnesol-related calcium channel blockers
US6538010B1 (en) * 2000-11-08 2003-03-25 Research Triangle Institute Compounds and methods for promoting smoking cessation
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7842727B2 (en) * 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
AU2003243272A1 (en) * 2002-05-22 2003-12-12 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
AU2003237397A1 (en) * 2002-06-04 2003-12-19 Sequenom, Inc. Diagnosing predisposition to fat deposition and therapeutic methods for reducing fat deposition and treatment of associated conditions
JP2006508642A (ja) * 2002-06-27 2006-03-16 ハークネス ファーマシューティカルズ，インコーポレイティド 脂肪の蓄積を減少させる方法と、関連疾患を治療するための方法
US20050239077A1 (en) * 2002-06-27 2005-10-27 Adam Gail I R Diagnosing predisposition to fat deposition and associated conditions
AU2003291097A1 (en) * 2002-11-20 2004-06-15 Errant Gene Therapeutics, Llc Treatment of lung cells with histone deacetylase inhibitors
CA2587013A1 (en) * 2004-11-08 2006-05-18 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7872023B2 (en) * 2005-02-17 2011-01-18 Research Triangle Institute Kappa opioid receptor ligands
US7399762B2 (en) * 2005-04-25 2008-07-15 Research Triangle Institute Opioid receptor agonist compounds and their use in treatment of pain
US7476679B2 (en) * 2005-07-26 2009-01-13 Research Triangle Institute Octahydroisoquinoline compounds as opioid receptor modulators
MX2009011360A (es) * 2007-04-20 2010-02-12 Acucela Inc Compuestos derivados de estirenilo para tratar enfermedades y trastornos oftalmicos.
US8048895B2 (en) * 2008-04-18 2011-11-01 Research Triangle Institute Kappa opioid receptor ligands
EP2539706B1 (en) 2010-02-24 2015-03-04 Research Triangle Institute Arylpiperazine opioid receptor antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194007A (en) * 1978-01-13 1980-03-18 Scott Eugene J Van α-Hydroxyretinoic acid, α-ketoretinoic acid and mixtures and their use in treating skin conditions
US4456618A (en) * 1982-10-15 1984-06-26 Sri International Naphthenic and heterocyclic retinoic acid analogues
US4568757A (en) * 1984-01-30 1986-02-04 Research Triangle Institute Configurationally locked retinoids

Also Published As

Publication number Publication date
NZ239844A (en) 1993-04-28
JP2943089B2 (ja) 1999-08-30
FI914405A (fi) 1992-03-22
IE66745B1 (en) 1996-02-07
JPH04270261A (ja) 1992-09-25
DK0476682T3 (da) 1995-04-03
PT99014B (pt) 1999-02-26
IE913318A1 (en) 1992-02-25
OA09514A (en) 1992-11-15
AU637756B2 (en) 1993-06-03
FI104168B1 (fi) 1999-11-30
IL99536A0 (en) 1992-08-18
EP0476682A1 (en) 1992-03-25
EP0476682B1 (en) 1995-02-01
CA2051766A1 (en) 1992-03-22
GR3014944T3 (en) 1995-05-31
AU8462691A (en) 1992-03-26
FI914405A0 (fi) 1991-09-19
US5141959A (en) 1992-08-25
ATE117979T1 (de) 1995-02-15
MX9101163A (es) 1992-05-04
FI104168B (fi) 1999-11-30
DE69107153D1 (de) 1995-03-16
IL99536A (en) 1995-10-31
ES2067822T3 (es) 1995-04-01
PT99014A (pt) 1992-08-31
DE69107153T2 (de) 1995-05-24

Similar Documents

Publication Publication Date Title
ZA917531B (en) Isoprenoid phospholipase a2 inhibitors and preparations comprising same
TNSN87033A1 (fr) TOLUNITRILES SUBSTITUES PAR DESα - HETEROCYCLES
ATE263771T1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
FI935944A0 (fi) Pyratsolopyrimidin- samt pyrimidinylbisfosfonestrar som anti- inflammatorer
SE8302694D0 (sv) Immunomodulating agent
DE3677471D1 (de) Pyrrolidinylamidesterderivate mit antiprolylendopeptidaseaktivitaet, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische zubereitungen.
AU9066498A (en) Substituted 6-alkylphenanthridines
SE8600046L (sv) Anvendning av en esterforening som temporer baktericid och produkt innehallande esterforeningen
GB1531946A (en) Cyclopentane derivatives useful as perfuming agents
FR2430232A1 (fr) Nouveaux acides arylaminobenzoiques utiles notamment comme agents hypoglycemiants
AU6306190A (en) Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis
MX9603348A (es) Derivados de disulfuro de amida indano-2-mercaptoacetilica novedosos utiles como inhibidores de encefalinasa.
WO1990012577A3 (en) Topical anti-angiogenic as hair growth inhibitors
ES8303372A1 (es) Procedimiento para la fabricacion de un compuesto de fenil-5-alquiltiazolidina-4-ona, 2-substituida
WO1990008529A3 (en) 7-alkoxycoumarins, dihydropsoralens, and benzodipyranones as photo-activated therapeutic agents and inhibitors of epidermal growth factor
NO303686B1 (no) Forbindelse til anvendelse ved fremstilling av alkylderivater av trazodon med CNS-aktivitet
FR2443460A1 (fr) Derives mercaptoacyles d'acides 4,5-dihydro-1h-pyrrole-2-carboxyliques et d'acides 1,4,5,6-tetrahydropyridine-2-carboxyliques, utiles comme agents hypotenseurs
ES2161870T3 (es) Esteres de benzoilacetato como fotoprotectores quelantes no sensibilizantes.
BR9611789A (pt) Processo para a preparação de derivados de ácido metoximino-fenilglioxílico
IE902272L (en) Compositions of 5-phenyl-2-furan ketones
EP0885886A4 (en) NEW PYRIDINECARBOXAMIDE DERIVATIVES
CA2183320A1 (en) Novel Mercaptoacetylamide Disulfide Derivatives Useful as Inhibitors of Enkephalinase and Ace
JPS5387334A (en) 1,4-bis 4', 4"-(beta-alkoxyethoxy)-benzoic acid
FR2418793A1 (fr) Nouveaux acides hexahydro-1-mercaptoacyl-1h-azepine-2-carboxyliques et leurs esters, utiles notamment comme inhibiteurs de l'hypertension reliee a l'angiotensine
PL141309B1 (en) Process for preparing novel heterocyclic derivatives of acetic acid